Last Price
0.521
Today's Change
-0.014 (2.61%)
Day's Change
0.501 - 0.575
Trading Volume
389,206
Market Cap
9 Million
Shares Outstanding
18 Million
Avg Volume
7,987,171
Avg Price (50 Days)
0.40
Avg Price (200 Days)
0.42
PE Ratio
-1.52
EPS
-0.33
Earnings Announcement
10-Apr-2025
Previous Close
0.54
Open
0.56
Day's Range
0.5011 - 0.575
Year Range
0.24 - 1.35
Trading Volume
389,206
1 Day Change
-6.34%
5 Day Change
16.53%
1 Month Change
43.21%
3 Month Change
28.49%
6 Month Change
52.82%
Ytd Change
65.38%
1 Year Change
-47.28%
3 Year Change
-88.64%
5 Year Change
-83.68%
10 Year Change
-45.53%
Max Change
-90.46%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.